- Noncoding RNAs (ncRNAs) are important regulators of biological development, cellular differentiation, tissue organization, and disease processes. Unlike messenger RNAs (mRNAs), which provide templates for protein synthesis, noncoding RNAs perform regulatory, structural, and catalytic functions without primarily encoding proteins. They influence gene expression at multiple levels, including chromatin organization, transcription, RNA processing, messenger RNA stability, translation, and protein activity. Through these mechanisms, noncoding RNAs help control how cells develop, differentiate, respond to environmental signals, and maintain normal physiological functions. Changes in their expression or activity can disrupt these processes and contribute to developmental abnormalities and diseases.
- Noncoding RNAs include several molecular classes with distinct biological functions. MicroRNAs (miRNAs) are short regulatory RNAs that usually bind complementary sequences in target messenger RNAs and promote their degradation or inhibit translation. Long noncoding RNAs (lncRNAs), generally defined as transcripts longer than 200 nucleotides without substantial protein-coding potential, regulate gene expression through interactions with DNA, RNA, and proteins. Circular RNAs (circRNAs) are produced through back-splicing and can participate in gene regulation and other cellular processes. Small interfering RNAs (siRNAs) contribute to sequence-specific RNA interference, while PIWI-interacting RNAs (piRNAs) help protect germ cells against transposable elements. Other noncoding RNAs, including transfer RNAs (tRNAs), ribosomal RNAs (rRNAs), small nuclear RNAs (snRNAs), and small nucleolar RNAs (snoRNAs), participate in translation, RNA processing, and cellular regulation.
- Noncoding RNAs play essential roles during embryonic development and early cellular differentiation. Embryonic development requires precise regulation of gene expression as cells divide, migrate, communicate, and acquire specialized functions. MicroRNAs help coordinate developmental transitions by controlling the expression of genes involved in cell proliferation, differentiation, apoptosis, and signalling. For example, the let-7 family of miRNAs participates in developmental timing and cellular differentiation, while the miR-1 and miR-133 families are associated with muscle development and cardiac function. Changes in miRNA expression can influence the balance between cell proliferation and differentiation, affecting the formation of tissues and organs.
- Long noncoding RNAs also contribute to embryonic development by regulating gene expression and chromatin organization. Some lncRNAs interact with chromatin-modifying proteins and transcriptional regulators to influence whether particular genes are active or repressed. XIST is a well-known lncRNA involved in X-chromosome inactivation in mammals, helping regulate gene dosage during development. Other lncRNAs participate in the regulation of developmental genes, cell identity, and lineage specification. Their effects may depend on their genomic location, cellular localization, molecular partners, and developmental stage.
- Noncoding RNAs are involved in the development and function of the nervous system. Neural development requires coordinated regulation of neural stem-cell proliferation, neuronal differentiation, axon formation, synapse development, and neuronal communication. Several miRNAs regulate neural cell differentiation and neuronal maturation, while lncRNAs contribute to neural lineage specification, synaptic function, and activity-dependent gene regulation. Changes in noncoding RNA expression may influence neuronal connectivity and brain development. CircRNAs are also abundant in nervous tissue, and some are associated with neuronal differentiation and synaptic processes, although the functions of many individual circRNAs remain under investigation.
- In muscle development, noncoding RNAs regulate the proliferation and differentiation of muscle precursor cells, myoblast fusion, muscle fibre formation, and muscle maintenance. The miR-1, miR-133, and miR-206 families are important examples of muscle-associated miRNAs. They participate in controlling muscle differentiation and the expression of genes involved in muscle development. LncRNAs and circRNAs may also influence muscle growth by interacting with transcription factors, RNA-binding proteins, and other regulatory molecules. These mechanisms are relevant to skeletal muscle development, cardiac function, muscle regeneration, and differences in muscle characteristics among animal breeds.
- Noncoding RNAs also participate in reproductive development and fertility. They contribute to germ-cell development, spermatogenesis, oocyte maturation, follicular development, embryo implantation, and placental function. PIWI-interacting RNAs are particularly important in germ cells because they help suppress transposable elements and maintain genome integrity. MicroRNAs and lncRNAs regulate genes involved in reproductive hormone signalling, cell differentiation, and reproductive tissue development. Abnormal noncoding RNA expression may affect gamete quality, embryonic development, fertility, and reproductive performance.
- The regulation of growth, metabolism, and organ development also involves noncoding RNAs. During tissue formation, miRNAs and lncRNAs influence signalling pathways responsible for cell proliferation, differentiation, and metabolic activity. In the liver, adipose tissue, pancreas, and skeletal muscle, noncoding RNAs can affect glucose metabolism, lipid metabolism, insulin signalling, and energy balance. Their regulatory effects help maintain physiological stability and coordinate responses to changes in nutrition and environmental conditions.
- Abnormal noncoding RNA expression or function is associated with many human diseases. Cancer is one of the most extensively studied areas of noncoding RNA research. Certain miRNAs act as tumour suppressors by inhibiting oncogenes, whereas others function as oncogenic miRNAs, commonly called oncomiRs, by reducing the expression of tumour-suppressor genes. For example, members of the miR-34 family are associated with tumour-suppressive regulation, while the miR-21 family is frequently overexpressed in several cancers and can promote tumour-associated processes. LncRNAs may influence cancer development by regulating cell proliferation, apoptosis, invasion, metastasis, and treatment resistance. CircRNAs are also investigated for their possible roles in tumour regulation, although their mechanisms and clinical significance vary among individual molecules and cancer types.
- Noncoding RNAs are also involved in neurological and neurodegenerative disorders. Altered miRNA and lncRNA expression has been reported in conditions such as Alzheimer’s disease, Parkinson’s disease, amyotrophic lateral sclerosis, and other neurological disorders. These RNA molecules may influence neuronal survival, inflammation, protein aggregation, synaptic function, and cellular stress responses. Some noncoding RNAs are being investigated as potential biomarkers because changes in their abundance may be detectable in blood, cerebrospinal fluid, and other biological samples. However, their diagnostic usefulness depends on disease specificity, sample quality, reproducibility, and independent clinical validation.
- Cardiovascular diseases are another important area of noncoding RNA research. MicroRNAs regulate cardiac development, heart muscle function, vascular formation, and endothelial cell activity. Abnormal miRNA expression may contribute to cardiac hypertrophy, myocardial injury, fibrosis, and vascular dysfunction. LncRNAs and circRNAs are also being investigated for their roles in heart development, inflammation, and tissue repair. Some circulating noncoding RNAs may provide information about cardiovascular injury and disease progression, although their clinical use requires further validation.
- Noncoding RNAs contribute to metabolic disorders by regulating glucose and lipid metabolism, insulin sensitivity, adipocyte differentiation, and energy homeostasis. Changes in miRNA and lncRNA expression have been associated with obesity, type 2 diabetes, fatty liver disease, and metabolic syndrome. They may influence the activity of genes involved in insulin signalling, lipid synthesis, inflammation, and energy storage. Noncoding RNAs also participate in immune regulation and inflammatory responses. Their abnormal expression may contribute to autoimmune diseases, chronic inflammation, and altered host responses to infection.
- Noncoding RNAs can also participate in host–pathogen interactions. Viruses may produce their own noncoding RNAs or modify host noncoding RNA expression to influence immune responses, cellular survival, and viral replication. Host miRNAs can sometimes restrict viral replication, while other interactions may support infection. Bacteria and other pathogens can also influence host RNA regulatory systems. Understanding these relationships may help identify new mechanisms of infection and potential therapeutic targets.
- Bioinformatics plays a central role in investigating noncoding RNA involvement in development and disease. RNA sequencing (RNA-seq) and small RNA sequencing are used to identify and quantify noncoding RNAs across tissues, developmental stages, and disease conditions. Tools such as FastQC, MultiQC, Cutadapt, STAR, HISAT2, Bowtie2, DESeq2, and edgeR support quality control, read alignment, and differential expression analysis. miRNA discovery tools such as miRDeep2 help identify known and candidate novel miRNAs, while lncRNA identification tools such as StringTie, CPC2, CPAT, and FEELnc support transcript assembly and coding-potential assessment. CircRNA detection tools such as CIRI2, CIRCexplorer2, and DCC identify circular transcripts through back-splice junctions.
- Reference databases provide important information for identifying and interpreting noncoding RNAs. miRBase and MirGeneDB support miRNA annotation, while RNAcentral and Rfam provide information about RNA sequences and families. NONCODE and LNCipedia contain lncRNA annotations, and circBase and circAtlas provide circRNA information. Resources such as miRTarBase and TarBase contain experimentally supported miRNA–target relationships. ENCORI, RNAInter, and NPInter provide information about RNA interactions and regulatory relationships. These resources help researchers connect expression patterns with known molecular functions and potential biological mechanisms.
- Functional analysis involves identifying the genes and pathways associated with differentially expressed noncoding RNAs. MicroRNA target prediction tools such as TargetScan, miRDB, miRanda, and RNAhybrid help identify potential target messenger RNAs. LncRNA functions can be investigated through genomic position, co-expression analysis, predicted RNA–protein interactions, and RNA–RNA interaction analysis. CircRNA studies may examine their host genes, potential miRNA interactions, and associations with RNA-binding proteins. Network analysis using Cytoscape can represent relationships among noncoding RNAs, messenger RNAs, proteins, and regulatory pathways. Gene Ontology (GO), KEGG, and Reactome enrichment analyses can help identify biological processes and pathways associated with candidate RNA molecules.
- Integration of noncoding RNA data with other omics technologies provides a broader understanding of their biological roles. Combining transcriptomics with genomics, epigenomics, proteomics, metabolomics, and chromatin accessibility data can reveal how noncoding RNAs interact with genetic and environmental regulatory mechanisms. For example, a genomic variant may alter the expression or processing of a noncoding RNA, which may subsequently influence the expression of target genes and affect a disease-related pathway. Single-cell RNA sequencing and spatial transcriptomics can provide information about cell-specific and tissue-specific noncoding RNA expression, while long-read sequencing can improve the identification of complex transcript structures and isoforms.
- In animal genomics and breeding, noncoding RNA research provides opportunities to understand the molecular regulation of economically important traits. MicroRNAs, lncRNAs, and circRNAs may influence growth, muscle development, feed efficiency, milk production, meat quality, egg production, wool characteristics, fertility, immune responses, and environmental adaptation. For example, muscle-associated miRNAs can contribute to the regulation of muscle differentiation and growth, while noncoding RNAs expressed in reproductive tissues may be associated with follicular development, spermatogenesis, and fertility. Changes in noncoding RNA expression in mammary tissue may also provide insights into milk synthesis and mammary gland development. Integrating noncoding RNA expression with quantitative trait loci (QTL), genome-wide association studies (GWAS), gene expression, and phenotypic measurements can help identify regulatory mechanisms associated with variation among livestock breeds and populations.
- Noncoding RNAs are also being investigated as potential diagnostic biomarkers and therapeutic targets. Their expression patterns may distinguish disease states, provide information about disease progression, or help predict treatment responses. Therapeutic approaches include antisense oligonucleotides, miRNA mimics, miRNA inhibitors, small interfering RNAs, and other RNA-based strategies. These approaches aim to increase or decrease the activity of specific RNA molecules or modify their interactions with target genes. However, challenges such as delivery to target tissues, molecular stability, off-target effects, immune responses, and tissue specificity must be addressed before many experimental approaches can become reliable clinical treatments.
- Despite significant progress, understanding noncoding RNA involvement in development and disease remains challenging. Many noncoding RNAs have low expression levels, complex structures, and highly tissue-specific functions. Their expression may vary with age, developmental stage, environmental conditions, and disease severity. Computational predictions of RNA targets and molecular interactions can generate false-positive results, and changes in expression do not necessarily establish a direct functional role. Some proposed mechanisms, including competing endogenous RNA (ceRNA) activity, require careful experimental evaluation. Independent validation using RT-qPCR, RNA-FISH, reporter assays, RNA pull-down, RNA immunoprecipitation, gene knockdown, overexpression, and CRISPR-based approaches is therefore important.
- Overall, noncoding RNAs are essential components of biological regulation, influencing development, cellular differentiation, tissue function, and disease processes. Their interactions with genes, proteins, and other RNA molecules create complex regulatory systems that operate throughout the life of an organism. Bioinformatics provides the computational methods needed to identify noncoding RNAs, analyse their expression, predict their molecular interactions, and investigate their biological functions. Continued advances in sequencing technologies, single-cell analysis, spatial transcriptomics, multi-omics integration, and functional validation are expected to deepen our understanding of noncoding RNA biology and expand its applications in medicine, biotechnology, and animal breeding.